Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Swiss Medical Weekly|September 8, 2021
Utilisation patterns and costs of lipid-lowering drugs in Switzerland 2013-2019Daphne Reinau, Nadine Schur, Sibylle Twerenbold, et al.
Vaccine|December 4, 2019
Coverage rates and timeliness of nationally recommended vaccinations in Swiss preschool children: A descriptive analysis using claims dataRahel Schneider, Daphne Reinau, Nadine Schur, et al.
Therapeutic Advances in Gastroenterology|May 5, 2021
Potentially inappropriate proton-pump inhibitor prescription in the general population: a claims-based retrospective time trend analysisLeander Muheim, Andri Signorell, Stefan Markun, et al.
Neuro-Degenerative Diseases|August 16, 2006
Cerebrospinal fluid profile of amyloid beta peptides in patients with Alzheimer's disease determined by protein biochip technologyAlessia S Maddalena, Andreas Papassotiropoulos, Charo Gonzalez-Agosti, et al.
International Journal of Public Health|June 5, 2023
The Impact of COVID-19 on Mental Healthcare Utilization in Switzerland Was Strongest Among Young Females-Retrospective Study in 2018-2020Yael Rachamin, Levy Jäger, Reka Schweighoffer, et al.
Plos One|August 5, 2015
Comparison of Outcomes and Costs of Ranibizumab and Aflibercept Treatment in Real-LifeMartin K Schmid, Oliver Reich, Livia Faes, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 24, 2023
Impact of the COVID-19 pandemic on antibiotic prescribing in high-prescribing primary care physicians in SwitzerlandSoheila Aghlmandi, Florian S Halbeisen, Pascal Godet, et al.
Frontiers in Cardiovascular Medicine|August 22, 2022
Secondary prevention of venous thromboembolism: Predictors and outcomes of guideline adherence in a long-term prospective cohort studyTamara Mertins, Henning Nilius, Robin Boss, et al.
JAMA Internal Medicine|February 6, 2023
Effect of Antibiotic Prescription Audit and Feedback on Antibiotic Prescribing in Primary Care: A Randomized Clinical TrialSoheila Aghlmandi, Florian S Halbeisen, Ramon Saccilotto, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 24, 2003
Treatment with the selective muscarinic m1 agonist talsaclidine decreases cerebrospinal fluid levels of A beta 42 in patients with Alzheimer's diseaseChristoph Hock, Alessia Maddalena, Andreas Raschig, et al.
Pageof 4